Based on ratings from 8 stock analysts, the Concentra Group Holdings Parent Inc stock price is expected to increase by 39.3% in 12 months. This is calculated by using the average 12-month stock price forecast for Concentra Group Holdings Parent Inc. The lowest target is $24 and the highest is $30. Please note analyst price targets are not guaranteed and could be missed completely.
Concentra Group Holdings Parent Inc has a total of 8 Wall St Analyst ratings. There are 7 buy ratings, 1 ratings, and 0 sell ratings. Since most analysts have a buy consensus rating, the expectation is that Concentra Group Holdings Parent Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of CON.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Ben Hendrix RBC Capital | Outperform | $30 | Maintains | Nov 4, 2024 |
Joanna Gajuk B of A Securities | Neutral | $24 | Downgrade | Oct 7, 2024 |
Ben Hendrix RBC Capital | Outperform | $33 | Initiates | Aug 20, 2024 |
David Macdonald Truist Securities | Buy | $29 | Initiates | Aug 19, 2024 |
Lisa Gill JP Morgan | Overweight | $29 | Initiates | Aug 19, 2024 |
Ann Hynes Mizuho | Outperform | $28 | Initiates | Aug 19, 2024 |
Jamie Perse Goldman Sachs | Buy | $32 | Initiates | Aug 19, 2024 |
Justin Bowers Deutsche Bank | Buy | $29 | Initiates | Aug 19, 2024 |
Joanna Gajuk B of A Securities | Buy | $30.5 | Initiates | Aug 19, 2024 |
Wells Fargo | Overweight | $27 | Initiates | Aug 19, 2024 |
When did it IPO
N/A
Staff Count
11,000
Country
United States
Sector/Industry
Healthcare/Medical Care Facilities
CEO
Mr. William Keith Newton
Market Cap
$2.74B
In 2023, CON generated $1.84B in revenue, which was a increase of 6.60% from the previous year. This can be seen as a signal that CON's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Concentra has opened a new medical center in Knoxville, Tennessee, expanding its presence in East Tennessee. The facility is located at 104 North Seven Oaks Drive.
Why It Matters - Concentra's expansion into Knoxville indicates growth potential, which may enhance revenue and market share, positively affecting investor sentiment and stock performance.
Summary - Select Medical Holdings has completed the distribution of 104,093,503 shares, about 81.7% of Concentra's common stock, owned by its subsidiary, Select Medical Corporation.
Why It Matters - Select Medical's distribution of Concentra shares reduces its ownership stake, potentially affecting its financials, stock price, and investor sentiment towards both companies.
Summary - Select Medical has completed the distribution of 104,093,503 shares of Concentra's common stock, representing about 81.7% of Concentra's outstanding shares.
Why It Matters - The distribution of Concentra shares by Select Medical significantly alters ownership structure, potentially impacting stock volatility and investor sentiment towards both companies.
Summary - Select Medical Holdings will distribute its equity interest in Concentra Group Holdings to stockholders, with details on the distribution ratio announced today.
Why It Matters - The special stock distribution of Concentra shares signifies a strategic move for Select Medical, impacting shareholder value and potentially altering market perceptions of both companies.
Summary - Flex Ltd will replace Azenta Inc. in the S&P MidCap 400, while Azenta will replace Envestnet Inc. in the S&P SmallCap 600, effective November 25, 2024. Envestnet is being acquired by Bain Capital.
Why It Matters - Changes in index composition can influence stock prices and investor sentiment. Flex Ltd's inclusion may attract more investment, while Azenta's move reflects its growth potential.
Summary - Concentra (NYSE: CON) has opened a new medical center in DeSoto, Texas, expanding its presence in the Dallas-Fort Worth Metroplex. The location is at 1111 North Interstate 35 E.
Why It Matters - Concentra's new medical center expands its market presence in a key region, potentially increasing revenue and market share, which can positively impact stock performance.